State Board of Administration of Florida Retirement System lifted its stake in Intrexon Corporation (NYSE:XON) by 2.1% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 77,176 shares of the biotechnology company’s stock after acquiring an additional 1,570 shares during the quarter. State Board of Administration of Florida Retirement System owned approximately 0.06% of Intrexon Corporation worth $1,859,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. State Street Corp grew its holdings in Intrexon Corporation by 34.0% during the first quarter. State Street Corp now owns 2,707,242 shares of the biotechnology company’s stock worth $53,664,000 after purchasing an additional 687,406 shares during the period. First Trust Advisors LP grew its holdings in Intrexon Corporation by 32.5% during the second quarter. First Trust Advisors LP now owns 1,537,088 shares of the biotechnology company’s stock worth $37,028,000 after purchasing an additional 376,780 shares during the period. Vanguard Group Inc. grew its holdings in Intrexon Corporation by 5.6% during the first quarter. Vanguard Group Inc. now owns 4,286,362 shares of the biotechnology company’s stock worth $84,954,000 after purchasing an additional 226,090 shares during the period. Credit Suisse AG grew its holdings in Intrexon Corporation by 273.7% during the first quarter. Credit Suisse AG now owns 183,555 shares of the biotechnology company’s stock worth $3,638,000 after purchasing an additional 134,434 shares during the period. Finally, Goldman Sachs Group Inc. grew its holdings in Intrexon Corporation by 60.0% during the first quarter. Goldman Sachs Group Inc. now owns 144,428 shares of the biotechnology company’s stock worth $2,862,000 after purchasing an additional 54,179 shares during the period. 82.27% of the stock is currently owned by institutional investors and hedge funds.

Shares of Intrexon Corporation (XON) opened at 19.83 on Thursday. The stock has a 50 day moving average of $19.87 and a 200-day moving average of $21.47. The firm’s market capitalization is $2.39 billion. Intrexon Corporation has a 52-week low of $17.03 and a 52-week high of $32.90.

Intrexon Corporation (NYSE:XON) last released its quarterly earnings data on Wednesday, August 9th. The biotechnology company reported ($0.16) EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.21) by $0.05. The company had revenue of $54.40 million during the quarter, compared to the consensus estimate of $57.17 million. Intrexon Corporation had a negative net margin of 60.63% and a negative return on equity of 19.08%. Intrexon Corporation’s revenue for the quarter was up 3.6% on a year-over-year basis. During the same period last year, the firm earned ($0.42) EPS. Equities analysts expect that Intrexon Corporation will post ($0.87) earnings per share for the current fiscal year.

In other news, Director Robert B. Shapiro purchased 2,850 shares of the business’s stock in a transaction on Tuesday, August 22nd. The stock was purchased at an average cost of $17.50 per share, with a total value of $49,875.00. Following the acquisition, the director now directly owns 43,157 shares in the company, valued at $755,247.50. The purchase was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Dean J. Mitchell purchased 5,000 shares of the business’s stock in a transaction on Friday, August 11th. The stock was purchased at an average cost of $18.33 per share, with a total value of $91,650.00. Following the completion of the acquisition, the director now owns 18,103 shares in the company, valued at $331,827.99. The disclosure for this purchase can be found here. Over the last ninety days, insiders purchased 144,569 shares of company stock valued at $2,719,429. 56.30% of the stock is owned by insiders.

XON has been the subject of a number of research analyst reports. BidaskClub upgraded Intrexon Corporation from a “strong sell” rating to a “sell” rating in a report on Thursday, June 15th. Zacks Investment Research cut Intrexon Corporation from a “hold” rating to a “sell” rating in a report on Thursday, July 13th. Finally, Northland Securities set a $30.00 price objective on Intrexon Corporation and gave the stock a “buy” rating in a report on Monday, August 7th. Two analysts have rated the stock with a sell rating, one has issued a hold rating and four have assigned a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus price target of $37.60.

WARNING: “State Board of Administration of Florida Retirement System Buys 1,570 Shares of Intrexon Corporation (XON)” was posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this story on another publication, it was illegally copied and republished in violation of U.S. and international copyright and trademark laws. The original version of this story can be viewed at https://www.thecerbatgem.com/2017/09/14/state-board-of-administration-of-florida-retirement-system-buys-1570-shares-of-intrexon-corporation-xon.html.

Intrexon Corporation Profile

Intrexon Corporation (Intrexon) forms collaborations to create biologically-based products and processes using synthetic biology. The Company’s domestic operations are in California, Florida, Maryland, and Virginia, and its primary international operations are in Belgium and Hungary. The Company designs, builds and regulates gene programs, which are deoxyribonucleic acid (DNA) sequences that consist of genetic components.

Institutional Ownership by Quarter for Intrexon Corporation (NYSE:XON)

Receive News & Stock Ratings for Intrexon Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intrexon Corporation and related stocks with our FREE daily email newsletter.